Both in Pharmaceuticals
Genprex vs Kairos Pharma
Over the past year GNPX returned −98.0% and KAPA returned −92.9%; their daily moves had a correlation of -0.01.
GNPX −98.0% KAPA −92.9%Growth of $1, one year, split-adjusted
| Metric | GNPX | KAPA |
|---|---|---|
| Price | $2.31 | $0.5050 |
| Market cap | $1.9M | $1.7M |
| Today | +3.59% | +6.65% |
| 1 month | −15.1% | −67.4% |
| 6 months | −88.1% | −87.0% |
| Year to date | −94.0% | −89.8% |
| 1 year | −98.2% | −93.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $15.2M | $2.6M |
| Dividend yield | — | — |
| Volatility (60d) | 81.9% | 580.6% |
| Short % of float | 15.3% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).